-
$1,500 Read More Neovacs SA – Product Pipeline Review – 2015
Global Markets Direct’s, ‘Neovacs SA - Product Pipeline Review - 2015’, provides an overview of the Neovacs SA’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Neovacs SA’s, complete with comparati... -
$4,995 Read More Alzheimer’s Therapeutics in Asia-Pacific Markets to 2021 – Growth Driven by Rising Prevalence, Growing Awareness and Expected L[...]
Alzheimer Disease (AD) is an irreversible, progressive neurodegenerative disease, characterized by cognitive impairment, memory loss and functional decline. Symptoms typically begin to first occur in patients in their mid-sixties, appearing in varying stages. The pathological features of AD compr... -
$4,995 Read More Asthma Therapeutics in Asia-Pacific Markets to 2021 – High Prevalence and Launch of Late-Stage Biologics will Drive the Market in[...]
Asthma is a common chronic inflammatory disease of the airways, characterized by recurrent attacks of breathlessness and wheezing, which vary in frequency and severity from patient to patient. The exact causes of asthma are currently unknown, and may be the result of a combination of factors, alt... -
$2,995 Read More Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies
GBI Research's latest report, "Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies", provides key insights into the global telehealth regulatory and market landscape, as well as its main applications in healthcare and associated sectors. The continued adoption of tel... -
$2,000 Read More Autism – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Autism - Pipeline Review, H1 2016’, provides an overview of the Autism pipeline landscape. The report provides comprehensive information on the therapeutics under development for Autism, complete with analysis by stage of development, drug target, mechanism of action (Mo... -
$2,000 Read More Atrial Fibrillation – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Atrial Fibrillation - Pipeline Review, H1 2016’, provides an overview of the Atrial Fibrillation pipeline landscape. The report provides comprehensive information on the therapeutics under development for Atrial Fibrillation, complete with analysis by stage of developmen... -
$2,000 Read More Diabetic Peripheral Neuropathy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Diabetic Peripheral Neuropathy - Pipeline Review, H1 2016’, provides an overview of the Diabetic Peripheral Neuropathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Diabetic Peripheral Neuropathy, complete wit... -
$2,000 Read More Mumps – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Mumps - Pipeline Review, H1 2016’, provides an overview of the Mumps pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mumps, complete with analysis by stage of development, drug target, mechanism of action (MoA),... -
$2,000 Read More Elephantiasis (Lymphatic Filariasis) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2016’, provides an overview of the Elephantiasis (Lymphatic Filariasis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Elephantiasis (Lymphatic Filaria... -
$2,000 Read More Streptococcus pyogenes Infections – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Streptococcus pyogenes Infections - Pipeline Review, H1 2016’, provides an overview of the Streptococcus pyogenes Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Streptococcus pyogenes Infections, com...
Sorry, there is no ad related to this category!
-
$4,995 Read More Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 –...
Type 1 Diabetes Mellitus (T1DM) is a chronic, progressive and serious disease characterized by a […]
-
$2,000 Read More Venous Leg Ulcers (Crural ulcer) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Venous Leg Ulcers (Crural ulcer) – Pipeline Review, H1 2016’, provides an […]
-
$2,000 Read More Constipation – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Constipation – Pipeline Review, H1 2016’, provides an overview of the Constipation […]
-
$2,500 Read More Bacteriuria Global Clinical Trials Review, H1, 2016
This report provides top line data relating to the clinical trials on Bacteriuria. Report includes […]
-
$4,700 Read More Biodefense Market Analysis By Product (Anthrax, Smallpox, Botulism, Radiation/Nu...
Global biodefense market is expected to reach USD 13.33 billion by 2020. Growing R&D investments […]
-
$1,995 Read More Country Focus: Healthcare, Regulatory and Reimbursement Landscape – China
GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement […]
-
$2,000 Read More Iron Deficiency Anemia – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Iron Deficiency Anemia – Pipeline Review, H1 2016’, provides an overview of […]
-
$2,000 Read More Epstein-Barr Viral Infections – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Epstein-Barr Viral Infections – Pipeline Review, H1 2016’, provides an overview of […]
-
$6,995 Read More Frontier Pharma: Ovarian Cancer – Identifying and Commercializing First-in...
Ovarian cancer is the sixth most common cancer in females and it also has the […]
-
$6,995 Read More Frontier Pharma: Breast Cancer – First-in-Class Innovation Clustered Aroun...
The breast cancer pipeline is the largest in the pharmaceutical industry, with 1,050 products in […]